Cavanaugh James H

Avg. Two Year Performance

(36%) Avg. Purchase Return
(17%) Compound
(102%) Avg. Sale Return
(42%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return20%(46%)(54%)19%(36%)
Purchase Success Rate2 of 41 of 40 of 41 of 40 of 4
Average Sale Return(7%)(6%)(4%)(24%)(102%)
Sale Success Rate0 of 10 of 10 of 10 of 10 of 1

MiddleBrook Pharmaceuticals...

Drugs » Drug Manufacturers - Other

Director, 10% Owner:

Holdings: 11.86M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

PharmAthene, Inc.

Financial Services » Diversified Investments

Director, 10% Owner:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Verenium Corp

Chemicals » Specialty Chemicals

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Vicuron Pharmaceuticals Inc

»

Director:

Holdings: 1.57M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Shire Pharmaceuticals Group...

Drugs » Drug Manufacturers - Other

Director:

Holdings: 386.56K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Leap Therapeutics, Inc.

Other » Other

Director:

Holdings: 262.05K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--